Most Popular Stories
- Walgreens plans 100 more retail clinics by mid-2009
- Disruptive doctor behavior causes mistakes, intimidates workers
- AHA survey: Negative profit margins for hospitals
- DOD, VA move to SOA architecture to build interoperable systems
- HHS: 60 percent of DME companies banned by Medicare may keep billing
- Cleveland Clinic lists potential conflicts of interest online
Poll
Featured Jobs
-
Chief Privacy Officer, Americas Region
IMS Health Incorporated - Plymouth Meeting, PA -
Florida Dermatology
StaffPointe, LLC - northeast , FL -
Georgia Internal Medicine
StaffPointe, LLC - north , GA -
California Internal Medicine
StaffPointe, LLC - near San Diego , CA -
Texas NP or PA CEx1134
StaffPointe, LLC - Dallas , TX
Events
- Avaya Patient Payment Recovery Webinar
Thursday, December 11, 2008 1-2pm
Paid Research Reports
- Stakeholder Opinions: Percutaneous Coronary Intervention - Adverse events with drug-eluting stents demand a new safety standard
- Impact of Pharmacogenomics on Public Healthcare Policy
- The Cardiovascular Disorders Market Outlook to 2012
- 2008 Trends to Watch: Pharmaceutical Technology
- Pharmaceutical Pricing and Reimbursement: Strategies for market access across the US, Europe, Japan and other key geographies
- Emerging markets series: Benchmarking key countries Brazil, Russia, India, China and Turkey
Popular Topics
FDA may get $275 million more for staff, outsourcing
The Bush administration is asking Congress for an additional $275 million for fiscal 2009 to allow the FDA to add more workers, expand programs and technology, and perhaps most interestingly, outsource some of its regulatory work. Given an earlier FDA request to expand its budget, the total added funds would come to about $404.7 million in fiscal 2009 than fiscal 2008, a 17.8 percent climb in spending. This will allow for 490 new FDA jobs. The funding request also asks Congress to expand FDA authority, notably to outsource some of its regulatory work by accrediting independent, third-party organizations to conduct voluntary inspections. These organizations would have the right to ban imports by a company if it delays, limits or denies access to agency inspectors.
To learn more about the new FDA budget (and outsourcing plans):
- read this Modern Healthcare article (reg. req.)
Related Articles:
FDA says it needs bigger budget
FDA moves to allay drug-import fears
FDA can't guarantee drug safety
Related Stories
- ALSO NOTED: Veterans demand free health plan;Drug makers rush to make generic Zoloft; and much more...
- Physicians, hospitals not thrilled by FDA proposals
- SPOTLIGHT: Outsiders should see FDA safety data
- N.Y. considers suing feds over SCHIP rules
- Congress poised to give more power to the FDA
- Who will pay for DTC pharma ad oversight?
- SPOTLIGHT: Should FDA's info be in all DTC ads?
- SPOTLIGHT: FDA can't manage foreign drugmaker inspections
- ALSO NOTED: Hospital group says quality reporting too costly; Health IT 'name game' creating headaches; and much more...
- ALSO NOTED: Consumer group sues FDA for stronger Cipro warnings; Study: Catheter infections preventable; and much more...
Comments
Post new comment
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site MapTHE FIERCEMARKETS NETWORKFierceFinance | FierceFinanceIT | FierceSarbox | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceBiotech | FierceBioResearcher | FiercePharma | FierceVaccines | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceVoIP | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe© 2008 FierceMarkets, Inc. All rights reserved. |
![]() |





